Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
Open Access
- 16 November 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 12 (1), 526
- https://doi.org/10.1186/1471-2407-12-526
Abstract
In this meta-analysis we aimed to determine the effectiveness and safety of hyperthermic intraperitoneal chemotherapy (HIPC) for patients with advanced gastric cancer who underwent gastrectomy.Keywords
This publication has 34 references indexed in Scilit:
- Recent patterns in gastric cancer: A global overviewInternational Journal of Cancer, 2009
- Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: The evolution of treatment strategies for advanced gastric cancerSeminars in Surgical Oncology, 2003
- Measuring inconsistency in meta-analysesBMJ, 2003
- A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP)Gastric Cancer, 2001
- Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinomaCancer, 1999
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled studyCancer, 1994
- Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin CCancer, 1988
- Selective Destruction of Cancers After Exposure to HeatAnnals of Surgery, 1962
- The Combination of Estimates from Different ExperimentsBiometrics, 1954